Author

S. E. Kasner

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

D. Weissman· 2 shared J. Nong· 2 shared J. S. Brenner· 2 shared J. W. Myerson· 2 shared O. A. Marcos-Contreras· 2 shared P. M. Glassman· 2 shared R. Y. Kiseleva· 2 shared S. Omo-Lamai· 2 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

D. Weissman

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Targeting lipid nanoparticles to the blood brain barrier to ameliorate acute ischemic stroke

J. Nong, P. M. Glassman, S. Reyes-Esteves, H. C. Descamps, V. V. Shuvaev, R. Y. Kiseleva, T. E. Papp, M.-G. Alameh, Y. K. Tam, B. L. Mui, S. Omo-Lamai, M. E. Zamora, T. Shuvaeva, E. Arguiri, C. A. Thaiss, , O. A. Marcos-Contreras

This paper develops VCAM-targeted lipid nanoparticles to enhance drug delivery to the blood-brain barrier in acute ischemic stroke, reducing infarct volume and mortality.

bioRxiv · Jun 12, 2023Pharmacology & Toxicology

Targeted nanocarriers coopting pulmonary leukocytes for drug delivery to the injured brain

P. M. Glassman, J. Nong, J. W. Myerson, V. Zuluaga-Ramirez, A. Rodriguez-Garcia, A. Mukalel, S. Omo-Lamai, L. R. Walsh, R. Y. Kiseleva, C. H. Villa, C. F. Greineder, S. E. Kasner, D. Weissman, M. J. Mitchell, S. Muro, , O. A. Marcos-Contreras

This paper demonstrates a strategy for targeted drug delivery to the injured brain by loading drugs onto pulmonary leukocytes using ICAM-targeting nanocarriers, showing increased brain uptake and therapeutic effect in a mouse model.

bioRxiv · Feb 4, 2022 · PreprintPharmacology & Toxicology